Renaud B, Brun-Buisson C
Service de Réanimation Médicale and Unité d'Hygiène et Prévention de l'Infection, Assistance Publique Hôpitaux de Paris and Université Paris XII, Hôpital Henri Mondor, Créteil, France.
Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90. doi: 10.1164/ajrccm.163.7.9912080.
We studied a cohort of 2201 patients hospitalized in 15 French intensive care units (ICUs) for > or = 48 h during a 4-mo period to assess the incidence and outcomes of primary and definite catheter-related bloodstream (CRB) or secondary nosocomial bloodstream infection (NBSI). Variables associated with ICU death and duration of stay were determined by logistic regression, and attributable mortality and length of stay (LOS) from a nested matched case-control (96 pairs) study, stratified on the source of bacteremia. Bacteremia occurred in 5% (95% CI 4.1-6%) of patients with > or = 48 h ICU stay. Primary, CRB, and secondary NBSI accounted for 29%, 26%, and 45% of the 111 episodes, respectively. NBSI was associated with a markedly increased risk of death (OR = 4.6; 95% CI 2.9-7.1) and an attributable mortality of 35% (95% CI, 28%-47%). In the case-control study, the excess mortality was 20% (p = 0.03) in patients with primary bacteremia and CRB, and 55% (p < 0.001) for secondary bacteremia; in patients with CRB only, the excess mortality was 11.5%. The median excess ICU LOS in survivors of NBSI was 9.5 d, and was similar, irrespective of its source. The risk of mortality associated with primary and catheter-related bacteremia appears much lower than that of secondary bacteremia, but is sizable, and the excess LOS incurred by the various categories of bacteremia is comparable. Differentiating catheter-related bacteremia from both primary and other secondary bacteremia appears warranted in studies conducted in critically ill patients.
我们对15个法国重症监护病房(ICU)中在4个月期间住院时间≥48小时的2201名患者进行了研究,以评估原发性和明确的导管相关血流感染(CRB)或继发性医院获得性血流感染(NBSI)的发生率和结局。通过逻辑回归确定与ICU死亡和住院时间相关的变量,并通过巢式匹配病例对照(96对)研究确定归因死亡率和住院时间(LOS),根据菌血症来源进行分层。在住院时间≥48小时的患者中,5%(95%CI 4.1 - 6%)发生了菌血症。在111例感染事件中,原发性、CRB和继发性NBSI分别占29%、26%和45%。NBSI与死亡风险显著增加相关(OR = 4.6;95%CI 2.9 - 7.1),归因死亡率为35%(95%CI,28% - 47%)。在病例对照研究中,原发性菌血症和CRB患者的额外死亡率为20%(p = 0.03),继发性菌血症患者为55%(p < 0.001);仅CRB患者的额外死亡率为11.5%。NBSI幸存者的ICU额外住院时间中位数为9.5天,无论其来源如何均相似。与原发性和导管相关菌血症相关的死亡风险似乎远低于继发性菌血症,但仍相当可观,且各类菌血症导致的额外住院时间相当。在危重症患者的研究中,区分导管相关菌血症与原发性和其他继发性菌血症似乎是有必要的。